Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Samidorphan + Olanzapine in Schizophrenia (ALK3831-302)
NCT01903837Phase 2Completed
- Sponsor
- Alkermes
- Start
- Jun 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of samidorphan, sponsored by Alkermes. Started Jun 2013; status: completed.
02
Drugs
samidorphan
Beyond the preview
Go deeper on NCT01903837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01903837.